189 related articles for article (PubMed ID: 8883499)
1. Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions.
Lüscher TF; Tanner FC; Noll G
Curr Opin Lipidol; 1996 Aug; 7(4):234-40. PubMed ID: 8883499
[TBL] [Abstract][Full Text] [Related]
2. The endothelium in acute coronary syndromes.
Noll G; Lüscher TF
Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
[TBL] [Abstract][Full Text] [Related]
3. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
Enseleit F; Hürlimann D; Lüscher TF
J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S21-30. PubMed ID: 11392475
[TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator.
Lüscher TF; Noll G
Atherosclerosis; 1995 Dec; 118 Suppl():S81-90. PubMed ID: 8821468
[TBL] [Abstract][Full Text] [Related]
5. [Role of nitric oxide and other endothelium-derived factors].
Stankevicius E; Kevelaitis E; Vainorius E; Simonsen U
Medicina (Kaunas); 2003; 39(4):333-41. PubMed ID: 12738901
[TBL] [Abstract][Full Text] [Related]
6. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options.
Britten MB; Zeiher AM; Schächinger V
J Intern Med; 1999 Apr; 245(4):315-27. PubMed ID: 10356593
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide.
Mombouli JV
Drugs; 1997; 54 Suppl 5():12-22. PubMed ID: 9429841
[TBL] [Abstract][Full Text] [Related]
8. The endothelium in coronary artery disease.
Ruschitzka FT; Noll G; Lüscher TF
Cardiology; 1997; 88 Suppl 3():3-19. PubMed ID: 9397288
[TBL] [Abstract][Full Text] [Related]
9. Vascular protection: current possibilities and future perspectives.
Lüscher TF
Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
[TBL] [Abstract][Full Text] [Related]
10. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2.
Yang Z; Arnet U; Bauer E; von Segesser L; Siebenmann R; Turina M; Lüscher TF
Circulation; 1994 May; 89(5):2266-72. PubMed ID: 8181152
[TBL] [Abstract][Full Text] [Related]
11. Non-lipid-lowering effects of statins on atherosclerosis.
Rosenson RS
Curr Cardiol Rep; 1999 Sep; 1(3):225-32. PubMed ID: 10980846
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors.
Mombouli JV; Illiano S; Nagao T; Scott-Burden T; Vanhoutte PM
Circ Res; 1992 Jul; 71(1):137-44. PubMed ID: 1318793
[TBL] [Abstract][Full Text] [Related]
13. Protection of endothelial function: targets for nutritional and pharmacological interventions.
Sudano I; Spieker LE; Hermann F; Flammer A; Corti R; Noll G; Lüscher TF
J Cardiovasc Pharmacol; 2006; 47 Suppl 2():S136-50; discussion S172-6. PubMed ID: 16794451
[TBL] [Abstract][Full Text] [Related]
14. Endothelial function as an end-point in interventional trials: concepts, methods and current data.
Lüscher TF; Noll G
J Hypertens Suppl; 1996 Sep; 14(2):S111-9; discussion S119-21. PubMed ID: 8934387
[TBL] [Abstract][Full Text] [Related]
15. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
Ruschitzka FT; Lüscher TF
Am Heart J; 1997 Aug; 134(2 Pt 2):S31-47. PubMed ID: 9313622
[TBL] [Abstract][Full Text] [Related]
16. Influence of lipoproteins on endothelial function.
Noll G; Lüscher TF
Thromb Res; 1994; 74 Suppl 1():S45-54. PubMed ID: 8073401
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone.
Lüscher TF
Basic Res Cardiol; 1993; 88 Suppl 1():15-24. PubMed ID: 8357330
[TBL] [Abstract][Full Text] [Related]
18. Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle.
Lüscher TF; Yang Z
Drugs; 1993; 46 Suppl 2():121-32. PubMed ID: 7512465
[TBL] [Abstract][Full Text] [Related]
19. Vascular effects of endothelin-1 in essential hypertension: relationship with cyclooxygenase-derived endothelium-dependent contracting factors and nitric oxide.
Taddei S; Virdis A; Ghiadoni L; Salvetti A
J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S37-40. PubMed ID: 10976779
[TBL] [Abstract][Full Text] [Related]
20. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
Hornig B; Arakawa N; Drexler H
Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
